MicroRNA miR-29b regulates diabetic aortic remodeling and stiffening

Patients with type 2 diabetes (T2D) are threatened by excessive cardiovascular morbidity and mortality. While accelerated arterial stiffening may represent a critical mechanistic factor driving cardiovascular risk in T2D, specific therapies to contain the underlying diabetic arterial remodeling have...

Descripción completa

Detalles Bibliográficos
Autores principales: Schellinger, Isabel N., Wagenhäuser, Markus, Chodisetti, Giriprakash, Mattern, Karin, Dannert, Angelika, Petzold, Anne, Jakubizka-Smorag, Joanna, Emrich, Fabian, Haunschild, Josephina, Schuster, Andreas, Schwob, Elisabeth, Schulz, Kei, Maegdefessel, Lars, Spin, Joshua M., Stumvoll, Michael, Hasenfuß, Gerd, Tsao, Philip S., Raaz, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957025/
https://www.ncbi.nlm.nih.gov/pubmed/33767915
http://dx.doi.org/10.1016/j.omtn.2021.02.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957025/
https://www.ncbi.nlm.nih.gov/pubmed/33767915
http://dx.doi.org/10.1016/j.omtn.2021.02.021

Ejemplares similares